Premium
Estrogen induces nitric oxide production in human bronchial epithelial cells
Author(s) -
Townsend Elizabeth A,
Thompson Michael A,
Cassivi Stephen D,
Pabelick Christina M,
Prakash Y S
Publication year - 2010
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.24.1_supplement.612.3
Subject(s) - estrogen , nitric oxide , medicine , endocrinology , enos , bronchoconstriction , estrogen receptor , respiratory epithelium , bronchodilation , chemistry , epithelium , endothelium , asthma , bronchodilator , nitric oxide synthase , lung , pathology , cancer , breast cancer
Women have a higher incidence and severity of asthma exacerbations compared to men. Asthma symptoms fluctuate with hormonal status suggesting a role for sex steroids in modulating bronchoconstriction. We have previously shown that acute estrogen decreases intracellular calcium in human airway smooth muscle thereby facilitating bronchodilation, similar to estrogen‐induced vasodilation. Akin to endothelium, airway epithelium is a source of nitric oxide (NO), a bronchodilator. We hypothesized that estrogens facilitate bronchodilation by generating NO in bronchial epithelium. In acutely dissociated human bronchial epithelial cells, 5–10 min exposure to 1 μM ACh or 17β‐estradiol (E2) (1 and 10 nM) resulted in increased DAF‐2 fluorescence (NO indicator). Both ER specific agonists THC (ERα) and DPN (ERβ) (10 nM,) induced NO production comparably. E2 effects were abrogated by the estrogen receptor (ER) antagonist ICI 182,780 (Faslodex®). eNOS phosphorylation was enhanced by E2 while E2‐induced NO production was attenuated by Ca2+ chelation (BAPTA; 20 μM, 30 min) and eNOS inhibition (L‐NAME). Overall, these data indicate a role for airway epithelium‐derived NO in the bronchodilatory effects of estrogens in human ASM. Supported by NIH grants HL090595 (CMP), HL088029 & HL56470 (YSP), and Mayo Graduate School (EAT).